Houston Business Journal, June 29, 2007 When The University of Texas Medical Branch was awarded funding in 2003 for one of two national biocontainment laboratories, officials expected the lab to help attract top-secret, defense-related research work to Galveston.  Now, with about a year still to go before the $167 million building opens, UTMB and several other universities across the country will begin a joint bioterrorism trial next month, sponsored by the National Institute of Allergy and Infectious Diseases, to test the effectiveness of a new smallpox vaccine.